UBS AM’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.6M | Buy |
1,193,929
+150,938
| +14% | +$1.46M | ﹤0.01% | 1290 |
|
|
2025
Q1 | $15.5M | Buy |
1,042,991
+26,640
| +3% | +$397K | ﹤0.01% | 1064 |
|
|
2024
Q4 | $15.2M | Buy |
1,016,351
+179,962
| +22% | +$2.69M | ﹤0.01% | 1065 |
|
|
2024
Q3 | $16M | Buy |
836,389
+4,029
| +0.5% | +$77.1K | ﹤0.01% | 1032 |
|
|
2024
Q2 | $17.2M | Buy |
832,360
+372,789
| +81% | +$7.72M | ﹤0.01% | 920 |
|
|
2024
Q1 | $8.64M | Sell |
459,571
-7,640
| -2% | -$144K | ﹤0.01% | 1053 |
|
|
2023
Q4 | $6.74M | Sell |
467,211
-51,053
| -10% | -$736K | ﹤0.01% | 1134 |
|
|
2023
Q3 | $9M | Sell |
518,264
-138,504
| -21% | -$2.4M | ﹤0.01% | 991 |
|
|
2023
Q2 | $15.4M | Hold |
656,768
| – | – | 0.01% | 826 |
|
|
2023
Q1 | $15.4M | Buy |
656,768
+12,983
| +2% | +$305K | 0.01% | 826 |
|
|
2022
Q4 | $18M | Buy |
643,785
+20,910
| +3% | +$584K | 0.01% | 783 |
|
|
2022
Q3 | $14.6M | Sell |
622,875
-67,692
| -10% | -$1.58M | 0.01% | 846 |
|
|
2022
Q2 | $23.3M | Buy |
690,567
+42,485
| +7% | +$1.43M | 0.01% | 700 |
|
|
2022
Q1 | $22.6M | Buy |
648,082
+25,432
| +4% | +$888K | 0.01% | 818 |
|
|
2021
Q4 | $19M | Buy |
622,650
+28,210
| +5% | +$859K | 0.01% | 909 |
|
|
2021
Q3 | $19.5M | Buy |
594,440
+15,262
| +3% | +$500K | 0.01% | 876 |
|
|
2021
Q2 | $17.5M | Buy |
+579,178
| New | +$17.5M | 0.01% | 923 |
|